HEPATITIS A VACCINE

A complete, commercial scale highly reproducible process for producing stable hepatitis A virus (HAV) comprises optimized growth, harvest, and antigen purification conditions, to yield a >95% pure HAV on the basis of protein. Further processing steps yield an inactivated HAV vaccine formulation w...

Full description

Saved in:
Bibliographic Details
Main Authors AUNINS,JOHN G, HAGEN,ANNA J, ORELLA,CHARLES J, HENNESSEY,JOHN P, SITRIN,ROBERT D, DEPHILLIPS,PETER A, ABOUD,ROBERT A, BUCKLAND,BARRY C, LEWIS,JOHN A, JUNKER,BETH, OLIVER,CYNTHIA NEWELL
Format Patent
LanguageEnglish
Published 28.11.1995
Edition5
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A complete, commercial scale highly reproducible process for producing stable hepatitis A virus (HAV) comprises optimized growth, harvest, and antigen purification conditions, to yield a >95% pure HAV on the basis of protein. Further processing steps yield an inactivated HAV vaccine formulation which is immunogenic, well tolerated, and efficacious in protection against infection by virulent HAV. The product content of protein, carbohydrate, lipid, DNA and RNA is characterized.
AbstractList A complete, commercial scale highly reproducible process for producing stable hepatitis A virus (HAV) comprises optimized growth, harvest, and antigen purification conditions, to yield a >95% pure HAV on the basis of protein. Further processing steps yield an inactivated HAV vaccine formulation which is immunogenic, well tolerated, and efficacious in protection against infection by virulent HAV. The product content of protein, carbohydrate, lipid, DNA and RNA is characterized.
Author BUCKLAND,BARRY C
HENNESSEY,JOHN P
AUNINS,JOHN G
OLIVER,CYNTHIA NEWELL
ORELLA,CHARLES J
JUNKER,BETH
SITRIN,ROBERT D
DEPHILLIPS,PETER A
ABOUD,ROBERT A
HAGEN,ANNA J
LEWIS,JOHN A
Author_xml – fullname: AUNINS,JOHN G
– fullname: HAGEN,ANNA J
– fullname: ORELLA,CHARLES J
– fullname: HENNESSEY,JOHN P
– fullname: SITRIN,ROBERT D
– fullname: DEPHILLIPS,PETER A
– fullname: ABOUD,ROBERT A
– fullname: BUCKLAND,BARRY C
– fullname: LEWIS,JOHN A
– fullname: JUNKER,BETH
– fullname: OLIVER,CYNTHIA NEWELL
BookMark eNrjYmDJy89L5WQQ9nANcAzxDPEMVnBUCHN0dvb0c-VhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfEeoSHmBpYWRo7GBBUAAGMnHws
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 5
ExternalDocumentID HUT70982A
GroupedDBID EVB
ID FETCH-epo_espacenet_HUT70982A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:16:01 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_HUT70982A3
Notes Application Number: HU19950000417
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19951128&DB=EPODOC&CC=HU&NR=T70982A
ParticipantIDs epo_espacenet_HUT70982A
PublicationCentury 1900
PublicationDate 19951128
PublicationDateYYYYMMDD 1995-11-28
PublicationDate_xml – month: 11
  year: 1995
  text: 19951128
  day: 28
PublicationDecade 1990
PublicationYear 1995
RelatedCompanies MERCK AND CO. INC
RelatedCompanies_xml – name: MERCK AND CO. INC
Score 2.4554448
Snippet A complete, commercial scale highly reproducible process for producing stable hepatitis A virus (HAV) comprises optimized growth, harvest, and antigen...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Title HEPATITIS A VACCINE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19951128&DB=EPODOC&locale=&CC=HU&NR=T70982A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3PT4MwFH6Z06g3xd8_Fg6GW-MoBdoDMaxAwERGlC27LaMU42UuDuO_b0GmXnZr2uSl7_D1e6993yvAHXUxkba0EJOEIaI4DbEC28gRFi2pRUr3p8o3deIJeZzZsx68brQwbZ_Qr7Y5okKUUHiv2_N69XeJFbS1lev74k1NvT9EuRcYZScXa8IHagQjL8zGwZgbnHvxxEifvdwdMor9HdhVMbTbQCGcjhpJyuo_n0RHsJcpU8v6GHpyqcEB33y7psH-U_farYYd8NYnoMVh5udJnrzovj71OU_S8BQGUZjzGCnr818_5vGk24V1Bn2V3MsL0G2zZENBaGk6FVlgwapFpZKgQoWRAtuiuoTzLUautq5cw2ErvDZNhOkN9OuPT3mrqLMuBq3b3x-EcO4
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT4MwFH-Z0zhvit8fk4Ph1jhKgXIghhUI6MaIwrLbMr6Ml7k4jP--pTL1slvTJr-0TX5977Xv9wpwR01MSr3UkFUSCxFu05CVYR0ZuUYLqpHC_MnyjYwgJY8zfdaB140WRtQJ_RLFETmjcs73WpzXq79LLFfkVq7vszfe9f7gJ7arFK1crHEfqOIObS-euBOmMGYHqRI924k5sCh2dmCX-9dmQwVvOmwkKav_9sQ_hL2YQy3rI-iUSwl6bPPtmgT74_a1mzdb4q2PQQq82EnCJHyRHXnqMBZG3gn0fS9hAeLo8991zIO0nYV2Cl0e3JfnIOtqYQ1yQgvVqMgC51a1qHgQlHE3Msd6Xl3A2RaQy60jt9ALkvFoPgqjpys4ECJsVUWYXkO3_vgsb7gZrbO-2IJvlERz4Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HEPATITIS+A+VACCINE&rft.inventor=AUNINS%2CJOHN+G&rft.inventor=HAGEN%2CANNA+J&rft.inventor=ORELLA%2CCHARLES+J&rft.inventor=HENNESSEY%2CJOHN+P&rft.inventor=SITRIN%2CROBERT+D&rft.inventor=DEPHILLIPS%2CPETER+A&rft.inventor=ABOUD%2CROBERT+A&rft.inventor=BUCKLAND%2CBARRY+C&rft.inventor=LEWIS%2CJOHN+A&rft.inventor=JUNKER%2CBETH&rft.inventor=OLIVER%2CCYNTHIA+NEWELL&rft.date=1995-11-28&rft.externalDBID=A&rft.externalDocID=HUT70982A